Peel Hunt reaffirmed their buy rating on shares of Craneware (LON:CRW) in a research report released on Tuesday. They currently have a GBX 2,100 ($29.01) price target on the stock.

Craneware (LON CRW) opened at GBX 1,695 ($23.42) on Tuesday. Craneware has a 1-year low of GBX 1,165 ($16.10) and a 1-year high of GBX 1,905 ($26.32). The firm has a market cap of $408.94 and a P/E ratio of 4,842.86.

TRADEMARK VIOLATION WARNING: “Peel Hunt Reiterates Buy Rating for Craneware (CRW)” was first posted by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are viewing this piece of content on another domain, it was copied illegally and reposted in violation of United States and international trademark & copyright laws. The correct version of this piece of content can be accessed at

About Craneware

Craneware plc is a United Kingdom-based company, which is engaged in the development, licensing and ongoing support of computer software for the United States healthcare industry. The Company’s Value Cycle Solutions span over five product families, which include Patient Engagement, Charge Capture & Pricing, Coding Integrity, Cost Analytics, and Revenue Collection & Retention.

Receive News & Ratings for Craneware Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Craneware and related companies with's FREE daily email newsletter.